UBS Group
THACW

UBS Group’s Thrive Acquisition Corporation Warrant THACW Stock Holding History

UBS Group’s Portfolio THACW Stock Details THACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300
Closed – – 11558
2022
Q3 		$0 Hold
300
– – ﹤0.01% 11488
2022
Q2 		$0 Hold
300
– – ﹤0.01% 11468
2022
Q1 		$0 Hold
300
– – ﹤0.01% 11337
2021
Q4 		$0 Buy
+300
New +$137 ﹤0.01% 11079

Other funds holding THACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

UBS Group's THACW Position: Q4 2022 in Review

UBS Group sold out of Thrive Acquisition Corporation Warrant (THACW) in Q4 2022, closing a stake of 300 shares.

UBS Group first reported a position in THACW in Q4 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 42 funds tracked by Wall St. Rank hold THACW as of Q4 2022.

  • UBS Group reported no remaining Thrive Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 300 Thrive Acquisition Corporation Warrant shares in Q4 2022.
  • UBS Group first reported a position in Thrive Acquisition Corporation Warrant in Q4 2021 and held it in 4 quarters.
  • UBS Group's Thrive Acquisition Corporation Warrant position peaked at $0 in Q3 2022.
  • 42 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.